SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ocera Therapeutics, Inc. Presents Data on the Prevalence of Mild Hepatic Encephalopathy Defined as Neurocognitive Impairment in Patients with Liver Cirrhosis at EASL Annual Meeting